CIPLA's weekly performance was disappointing, with a return of -1.1%, underperforming its peers. The stock's high volatility of 52.54% contributed to its poor performance, making it a risky investment this week. In comparison, peers SUNPHARMA and GRASIM outperformed CIPLA, while DIVISLAB's performance was similar. Overall, CIPLA's weekly performance was marked by high risk and poor returns.

[Volatility: 52.54%]